MoneyWorks4Me

Neuland Laboratories - Quaterly Results

10 May 2024 Evaluate
A decrease in the sales to Rs. 3850.10 millions was observed for the quarter ended March 2024. The sales stood at Rs. 4070.73 millions during the similar quarter previous year.A slender decline of -20.00% was recorded to Rs. 676.06  millions from Rs. 845.10 millions in the corresponding previous quarter.Operating profit for the quarter ended March 2024 decreased to 1121.51 millions as compared to 1277.81 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 3850.10 4070.73 -5.42 15585.80 11911.98 30.84 15585.80 11911.98 30.84
Other Income 53.57 80.64 -33.57 125.44 97.48 28.68 125.44 97.48 28.68
PBIDT 1121.51 1277.81 -12.23 4744.65 2810.56 68.82 4744.65 2810.56 68.82
Interest 36.09 42.89 -15.85 139.97 130.67 7.12 139.97 130.67 7.12
PBDT 1085.42 1234.92 -12.11 4604.68 2679.89 71.82 4604.68 2679.89 71.82
Depreciation 164.62 134.70 22.21 596.99 527.76 13.12 596.99 527.76 13.12
PBT 920.80 1100.22 -16.31 4007.69 2152.13 86.22 4007.69 2152.13 86.22
TAX 244.74 255.12 -4.07 1011.73 520.94 94.21 1011.73 520.94 94.21
Deferred Tax 25.50 1.76 1348.86 15.87 17.04 -6.87 15.87 17.04 -6.87
PAT 676.06 845.10 -20.00 2995.96 1631.19 83.67 2995.96 1631.19 83.67
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 29.13 31.39 -7.20 30.44 23.59 29.02 30.44 23.59 29.02
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..